RADIOPHARMACEUTICALS FOR MUS DASH 8 3 MONTH EXTENSION P00004
Research this with AI
Ask AI researches this public topic. CaptureIQ qualifies the opportunity, manages the pursuit, and prepares review-ready materials.
Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.
Award details
- Award ID
- 36C25926P0013
- Contractor
- UNIVERSITY OF OKLAHOMA
- Awarding agency
- Department of Veterans Affairs
- Sub-agency / office
- Department of Veterans Affairs
- Award amount
- $358,241
- Period of performance
- Oct 1, 2025 – Jun 30, 2026
- Place of performance
- OKLAHOMA CITY, OK, 731043650, USA
- Competition
- NOT COMPETED UNDER SAP · Set-aside: NO SET ASIDE USED. · 1 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $444,488 · Obligated $444,488 · Potential value $444,488 · Latest action obligation $86,247
Public award description
RADIOPHARMACEUTICALS FOR MUS DASH 8 3 MONTH EXTENSION P00004
Related intelligence
- Contractor: UNIVERSITY OF OKLAHOMA
- Agency: Department of Veterans Affairs
- Federal market intelligence software
Related Federal Awards
- · 75N91022F00002 — TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,435,788
- · 75N91025F00001 — BASE IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE… · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,234,179
- · 75N92023F00001 — STRONG HEART STUDY (SHS)- OKLAHOMA UNIVERSITY HEALTH CENTER (OUHSC) COORDINATING CENTER(CC) SUBTASK B.2 - P… · DEFINITIVE LOGIC CORPORATION · Department of Health and Human Services · $1,218,378
- · 75N91022F00004 — CHEMOPREVENTION WITH MITOCHONDRIA-TARGETED HONOKIOL IN MOUSE MODELS OF LUNG CANCER: ADENOCARCINOMA AND SQUA… · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,201,554
- · 75N91026F00001 — TRIPLE NEGATIVE BREAST CANCER VACCINES · Department of Health and Human Services · $1,147,754
- · 75N91023F00001 — BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BI… · MEDIDATA SOLUTIONS, INC. · Department of Health and Human Services · $1,140,397